Methods:
A single center retrospective review of consecutive patients with ICD-9, ICD-10 and CPT codes for diagnosis of Achilles tendon and calcaneal coding were reviewed from January 2007-May2017. Inclusion criteria included active duty military, failure of at least 3 months of conservative management and surgical treatment utilizing a retrocalcaneal exostectomy, Achilles tendon debridement followed by reattachment as necessary. Radiographic and clinical data collection was completed on all patients who met inclusion criteria to determine pre-and post-operative changes in pain and function. VAS pain scores were collected pre-op, and at 3, 6 12 and 24mo post-op. Operative reports were reviewed to confirm specific operative findings and repair technique. Surgical treatment was achieved with medial incision, fluoroscopy guided spur/Haglund deformity resection and reattachment of the Achilles tendon utilizing suture anchor constructs. Return to duty and profile status were recorded as outcome measures.
Results: Our data analysis included 70 patients with the majority of patient from the Army (41 pts). Average age at treatment was 36.6yo (range, 21-54). Tobacco use was observed in 13 patients (18.57%). Length of pre-operative physical therapy averaged 6.5 months (range, 2-36mo). Other modalities prior to operative correction were also recorded with 20% receiving a PRP injection, 1.43% received a steroid injection, 14% of patients received ECSWT. Surgical treatment complications were observed in 16 patients (13%). VAS scores significantly improved at one year from 5.6 pre-op to 3.2 post-op (n=26.) At 1 year,60% of patient went onto return to full duty, 25% of patients remained on profile, 5% of patients retired, 10% of patients went onto medical evaluation board for separation from the military.
Conclusion:
To our knowledge, this is the first study to evaluate the outcomes of insertional Achilles tendinopathy in an active military population. Insertional Achilles tendinopathy prevalence within the military is a common condition with incidence rates likely higher than the general population which previously reported to between 15-24%. In conclusion, with a 60% return to duty rate and significant reduction of subjective pain scores, this is a viable treatment option for patients who could not otherwise remain on active duty but the complication rate is high (13%) and patients and providers should consider the risks during their shared decision making process.
